Back
ESC Professional Premium Access

Prognosis of atrial fibrillation with or without comorbidities. Analysis of younger adults from a nationwide database

Session: Atrial fibrillation in context of concomitant medical conditions
Topic: Epidemiology, Prognosis, Outcome
Speaker: Professor L. Fauchier (Tours, FR)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Professor Laurent Fauchier

University Hospital of Tours, Tours (France)
14 presentations
1 follower

7 more presentations in this session

Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial

Speaker: Mr A. Pandey (Hamilton, CA)

Access
Abstract
Slides
Like
Thumbnail

Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation

Speaker: Doctor R. Nishinarita (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

Sodium-glucose cotransporter 2 inhibitors not only suppress recurrence after atrial fibrillation ablation but also cause atrial reverse remodeling

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Access
Abstract
Slides
Like
Thumbnail

Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.

Speaker: Doctor K. Iwakura (Osaka, JP)

Access
Abstract
Slides
Like
Thumbnail

Influence of obesity and overweight on the association between sleep-disordered breathing and atrial fibrillation: the DASAP-HF study

Speaker: Professor G. Boriani (Modena, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Atrial fibrillation in context of concomitant medical conditions

Speakers: Professor L. Fauchier, Mr A. Pandey, Doctor R. Nishinarita, Associate Professor T. Mine, Doctor K. Iwakura...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources